GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Steminent Biotherapeutics Inc (ROCO:7729) » Definitions » Short-Term Capital Lease Obligation

Steminent Biotherapeutics (ROCO:7729) Short-Term Capital Lease Obligation : NT$13.68 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Steminent Biotherapeutics Short-Term Capital Lease Obligation?

Steminent Biotherapeutics's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$13.68 Mil.

Steminent Biotherapeutics's quarterly Short-Term Capital Lease Obligation increased from Dec. 2023 (NT$13.15 Mil) to Jun. 2024 (NT$13.47 Mil) and increased from Jun. 2024 (NT$13.47 Mil) to Dec. 2024 (NT$13.68 Mil).

Steminent Biotherapeutics's annual Short-Term Capital Lease Obligation increased from Dec. 2022 (NT$7.17 Mil) to Dec. 2023 (NT$13.15 Mil) and increased from Dec. 2023 (NT$13.15 Mil) to Dec. 2024 (NT$13.68 Mil).

Steminent Biotherapeutics Short-Term Capital Lease Obligation Historical Data

The historical data trend for Steminent Biotherapeutics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steminent Biotherapeutics Short-Term Capital Lease Obligation Chart

Steminent Biotherapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Capital Lease Obligation
7.63 7.90 7.17 13.15 13.68

Steminent Biotherapeutics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial 7.17 10.55 13.15 13.47 13.68

Steminent Biotherapeutics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Steminent Biotherapeutics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Steminent Biotherapeutics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Steminent Biotherapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Steminent Biotherapeutics Inc (ROCO:7729) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
ROCO:4186 ROCO:7814 ROCO:7790 ROCO:6879 ROCO:4195 ROCO:4131 ROCO:6564 ROCO:6810 ROCO:6850 ROCO:6236 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No.16,Wenhu Street, Neihu District, Taipei, TWN, 11445
Website
http://www.steminent.com
Steminent Biotherapeutics Inc is a international stem cell biopharmaceutical company which has stable and efficient stem cell platform technology, aiming to develop live cell drugs to treat degenerative diseases as well as acute and life-threatening diseases. With its Stemchymal which is proprietary technology platform generating the standardized, clinical grade, allogeneic stem cells isolated from human adipose tissue. It is operated in strict compliance to regulations of Taiwan, the US, and Japan.

Steminent Biotherapeutics Headlines

No Headlines